Corrections and clarifications — January 8, 2022

In a report “WHO yet to authorise use of Covaxin among adolescents” (Inside pages, January 7, 2022), the paragraph, “ However, the Ministry guidelines wrongly state that... for the age group 15-18 ”, should have read as, “For such beneficiaries [15-18 years], option for vaccination would only be available for Covaxin as this is the only vaccine with EUL [emergency use listing] for the age group 15-18.”